219 completed, 39 terminated, 34 unknown, 11 recruiting. 115 Phase 4, 96 Phase 3, 35 Not applicable, 35 Phase 2, 21 Phase 1.
Follow Quetiapine Fumarate: new trials by email Literature Review of Quetiapine Fumarate trials Research Report on Quetiapine Fumarate
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| RCT: Trazodone vs Quetiapine vs Placebo for Treating ICU Delirium (TraQ) Trazodone, Quetiapine, Placebo - Delirium, Morality | Phase 4 | Withdrawn | University of Southern California | 2028-03-01 | 2026-05-04 | |
| Study of rTMS in Maintenance in Treatment Resistant Depression Transcranial Magnetic Stimulation, quetiapine - Treatment Resistant Depression (TRD) | Phase 3 | Not yet recruiting | All India Institute of Medical Sciences, Bhubaneswar | 68 | 2026-08-30 | 2026-08-12 |
| Efficacy and Mechanism of IPSRT for Bipolar II Disorder Quetiapine (drug), Psychopharmacological treatment - Bipolar Disorder II | Phase 2 | Not yet recruiting | First Affiliated Hospital of Zhejiang University | 216 | 2026-07-01 | 2026-06-17 |
| Quality of Life, Safety and Compliance of Patients Using Monotherapy or Combinatorial Therapy With Quetiapine for Treatment of Schizophrenia or Bipolar Affective Disorder Quetiapine (drug), quetiapine + aripiprazole, quetiapine + haloperidol - Schizophrenia, Bipolar Affective Disorder | Recruiting | Bosnalijek D.D | 500 | 2025-10-30 | 2026-10-15 | |
| Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure Clozapine, Esketamine Nasal Product, Escitalopram - Schizophrenia and Related Disorders, Major Depressive Disorder | Phase 3 | Recruiting | Dr. Inge Winter | 1254 | 2025-04-27 | 2026-01-22 |
| The Effect of a Six Week Intensified Pharmacological Treatment for Bipolar Depression Compared to Treatment as Usual in Subjects Who Had a First-time Treatment Failure on Their First-line Treatment. Escitalopram, Sertraline, Venlafaxine - Bipolar Depression | Phase 3 | Recruiting | Dr. Inge Winter | 418 | 2025-02-11 | 2025-09-26 |
| Sequential Multiple Assignment Randomized Trial for Bipolar Depression Cariprazine, Aripiprazole/Escitalopram combination, Quetiapine - Bipolar I Disorder, Depression | Phase 4 | Active not recruiting | Massachusetts General Hospital | 2726 | 2024-10-01 | 2025-12-16 |
| Magnetic Seizure Therapy for Psychotic Disorders Magnetic seizure therapy by Magnetic stimulator, Antipsychotic medications (such as olanzpine, risperidone, aripiprazole, quetiapine, amisulpride, etc) - Psychotic Disorders | Not applicable | Recruiting | Shanghai Jiao Tong University School of Medicine | 50 | 2024-09-01 | 2025-11-25 |
| Quetiapine Versus Trazadone in Women With Postpartum Depression Trazodone, Quetiapine - Postpartum Depression | Early Phase 1 | Unknown | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 50 | 2024-09-01 | 2024-08-09 |
| Quetiapine to Reduce Post Concussive Syndrome After Mild Traumatic Brain Injury (mTBI) Quetiapine Fumarate, TAU - Mild Traumatic Brain Injury | Phase 3 | Recruiting | Foundation for Advancing Veterans' Health Research | 146 | 2024-07-09 | 2025-07-11 |
| Trazodone vs. Quetiapine for the Treatment of ICU Delirium Trazodone, Quetiapine - Delirium, Delirium of Mixed Origin | Terminated | University of Southern California | 10 | 2024-06-01 | 2026-05-04 | |
| Lumateperone for the Improvement of Apathy in Patients With Psychotic Symptoms. Lumateperone 42 mg, Risperidone 2 mg - Apathy, Schizophrenia | Phase 3 | Recruiting | Louisiana State University Health Sciences Center Shreveport | 80 | 2024-06-01 | 2024-07-01 |
| Improving Sleep After TKA Using Mirtazapine and Quetiapine Mirtazapine, Quetiapine, Placebo - Osteo Arthritis Knee, Insomnia | Not applicable | Not yet recruiting | St. Anna Ziekenhuis, Geldrop, Netherlands | 165 | 2024-01-01 | 2023-06-02 |
| Efficacy of Hydroxyzine for Patients With Panic Disorder Hydroxyzine, Escitalopram Oxalate - Panic Disorder | Phase 4 | Not yet recruiting | Sultan Qaboos University | 80 | 2023-12-30 | 2023-02-21 |
| Efficacy of Melatonin, Low-dose Quetiapine, or Placebo in Patients With Psychiatric Disorders and Comorbid Insomnia Melatonin, Quetiapine, Placebo - Psychiatric Disorders, Insomnia | Phase 2 / Phase 3 | Recruiting | Lone Baandrup | 255 | 2023-09-18 | 2025-04-24 |
| An Exploratory Analysis of Immune and Inflammatory Response Associated With Clozapine Clozapine, Antipsychotics,Other (non-Clozapine) - Treatment-resistant Schizophrenia | Phase 4 | Terminated | Ohio State University | 5 | 2023-08-16 | 2026-02-25 |
| Valproate Alone or in Combination With Quetiapine for Severe COVID-19 Pneumonia With Agitated Delirium Valproate, Quetiapine, Standard of Care - Covid19, Hyperactive Delirium | Phase 4 | Withdrawn | University of Miami | 2023-03-28 | 2023-03-31 | |
| Quetiapine in Prevention of Delirium Quetiapine - Delirium | Phase 2 | Completed | Ain Shams University | 90 | 2023-03-01 | 2023-07-10 |
| Quetiapine as Prophylaxis for Delirium in CABG Quetiapine - Delirium | Not applicable | Unknown | Ain Shams University | 60 | 2022-12-04 | 2023-04-06 |
| Correlation of Genetic Variations With Clinical Response in Substance Use Disorder Quetiapine, olanzapine, mirtazapine, carbamazepine, sertraline, amitriptyline, chlorpromazine and risperidone - Substance Use Disorders, Substance Dependence | Unknown | Alexandria University | 200 | 2022-11-28 | 2023-04-27 |
Showing 20 of 315. Sign in to see all of them.
Schizophrenia (100) · Bipolar Disorder (77) · Psychotic Disorders (47) · Depression (26) · Depressive Disorder, Major (22) · Mania (13) · Anxiety Disorders (10) · Delirium (10) · Dementia (10) · Alcoholism (9) · Generalized Anxiety Disorder (8) · Substance-Related Disorders (8) · Stress Disorders, Post-Traumatic (7) · Cocaine-Related Disorders (6) · Phobia, Social (6)
AstraZeneca (62) · University of Cincinnati (9) · H. Lundbeck A/S (6) · Massachusetts General Hospital (6) · Otsuka Pharmaceutical Development & Commercialization, Inc. (6) · Astellas Pharma Inc (4) · New York State Psychiatric Institute (4) · The University of Texas Health Science Center at San Antonio (4) · University of Texas Southwestern Medical Center (4) · Central South University (3) · Fundación Marques de Valdecilla (3) · Indiana University (3) · Janssen Research & Development, LLC (3) · Janssen Scientific Affairs, LLC (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3)
United States (149) · Germany (35) · Canada (32) · China (23) · Spain (16) · South Korea (13) · Bulgaria (12) · Russia (12) · Taiwan (11) · Czechia (10) · Finland (10) · India (10) · Poland (10) · Romania (10) · Ukraine (10)
Catherine Datto, MD (5) · Benedicto Crespo-Facorro, Professor (3) · Melissa P DelBello, MD (3) · Art Lazarus, MD (2) · Dr. Nirav Gandhi, M.D. (2)
PMID 24816198, PMID 24067192, PMID 26474010, PMID 23497790, PMID 24175720, PMID 22143997, PMID 23485955, PMID 24394383, PMID 32792252, PMID 19956459, PMID 22027845, PMID 22035648, PMID 23672772, PMID 23673347, PMID 23761037, PMID 24108148, PMID 24175721, PMID 29856773, PMID 30097769, PMID 32840872, PMID 37756123, PMID 38958149, PMID 41401709, PMID 10082232, PMID 12075033, PMID 15082703, PMID 15817019, PMID 1593914, PMID 16172203, PMID 16585434, PMID 16585435, PMID 16831113, PMID 17035647, PMID 17054789, PMID 17151158, PMID 17151159, PMID 17592906, PMID 17632217, PMID 17854242, PMID 17984395, PMID 18021496, PMID 18041437, PMID 18058285, PMID 18312058, PMID 18519523, PMID 18681757, PMID 19036233, PMID 19102734, PMID 19157776, PMID 19324499
2005 (4), 2009 (2), 2023 (2), N01MH090001 (2), N01MH90001 (2), 2008 (1), 2019 (1), K12DA000357 (1), K23DA021209 (1), P30MH086045 (1), P50DA009236 (1), R01DA022221 (1), R01DA031826 (1), R01DK097599 (1), R01MH057292 (1)